Us2.ai announced that it has raised US$15 million in a Series A round led by IHH Healthcare and Heal Partners, with participation from Pappas Capital.
Round co-led by Sequoia India and Singapore government-linked strategic investor EDBI.
See-Mode’s first product, Augmented Vascular Analysis, has been approved as a Class B medical device.
Medtech company established via a merger between A*STAR MedTech spin-off MiRXES and venture capital firm Venturecraft.
Investment marks an important milestone for Singapore’s medtech startup scene.
Early cancer detection saves lives and one Malaysian company – Mobecomm Technologies – is providing the technology to do just that.
Fares Zahir, the CEO of Xeraya Capital, a Khazanah-owned VC firm, joins the What’s Next conference as a panellist, and here shares what the low-key fund does and how some of its investments have fared.
The French government wants South-East Asian startups, including those based in Singapore, to become of its ecosystem via the French Tech Ticket competition.
SUBANG Jaya Medical Centre (SJMC) said it will be using the Varian TrueBeam Radiotherapy System, which it described as a breakthrough technology in the fight against cancer.